Watch for New "Follow-On" Mealtime Insulin Admelog (Lispro)

April 2018

Admelog (AD-mah-log) will compete with Humalog as a new BRAND of insulin lispro.

This is similar to the situation with Basaglar and Lantus.

Admelog is not a generic...and isn't technically a biosimilar in the U.S. Instead, FDA calls Admelog and Basaglar "follow-on" brands...they use safety and efficacy data from the original brands for faster approval.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Diabetes Don't Think of A1C Goals as "One-Size-Fits-All"
Vaccines Resolve Common Questions About Shingrix Administration
Cardiology Manage New Warnings About Clarithromycin and Cardiovascular Risk
Infectious Diseases Lean Toward Oral Vancomycin for Initial Treatment of C. diff Diarrhea
Fentanyl Patches Follow Safeguards When Prescribing Fentanyl Patches
Rheumatoid Arthritis Consider Using Subcutaneous Methotrexate More for Rheumatoid Arthritis
Cannabinoids Know How the Rx Cannabinoids Compare
Men's Health Consider if Meds or Supplements May Be Contributing to Male Infertility
Asthma Close the Gap in Asthma Care in Kids
Aspirin Be Prepared With the Latest Answers About Aspirin
Insulin Watch for New "Follow-On" Mealtime Insulin Admelog (Lispro)

Watch for New "Follow-On" Mealtime Insulin Admelog (Lispro)

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents